Red blood cells from horses, turkeys, and guinea pigs

Ended Definitive Contract Awarded Last action

Contract number
75D30123C18277
Awardee
Awarding agency
Obligated
$836,392

Award facts

Opportunity
  • 75D30123R72848 Solicitation number
Contract value 99% obligated
$847,104.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Ottsville, PA 18942, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 · EO 14398 $0
Exercise an Option P00004 $296,048
Exercise an Option P00003 $271,682
Supplemental Agreement for work within scope P00002 $0
Other Administrative Action P00001 $0
Original award $268,662

About this award

The Centers for Disease Control and Prevention awarded an $847,104 definitive contract to Lampire Biological Labs Inc. for red blood cells from horses, turkeys, and guinea pigs on September 22, 2023, under no set-aside.

Place of performance is Ottsville, Pennsylvania. The contract is priced firm fixed price with an ultimate completion date of September 21, 2026.

Quick answers

Who was awarded contract 75D30123C18277?

75D30123C18277 was awarded to Lampire Biological Labs Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 22, 2023.

How much is contract 75D30123C18277 worth?

The government has obligated $836,392 on 75D30123C18277. Its current value, with exercised options, is $847,104.

Was contract 75D30123C18277 competed?

The extent of competition for 75D30123C18277 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award